Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Kolassa E(M, Bynum LA, Holmes E. Limitations and potential misinterpretation of the National Disease and Therapeutic Index. Intl J of Pharm & Health Mrkt 2013. [DOI: 10.1108/17506121311315409] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]

For:	Kolassa E(M, Bynum LA, Holmes E. Limitations and potential misinterpretation of the National Disease and Therapeutic Index. Intl J of Pharm & Health Mrkt 2013. [DOI: 10.1108/17506121311315409] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]

Number	Cited by Other Article(s)
1	National trends in hydroxyurea and opioid prescribing for sickle cell disease by office‐based physicians in the United States, 1997‐2017. Pharmacoepidemiol Drug Saf 2019;28:1246-1250. [DOI: 10.1002/pds.4860] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Revised: 06/10/2019] [Accepted: 06/26/2019] [Indexed: 01/07/2023] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Cited by Other Article(s)

National trends in hydroxyurea and opioid prescribing for sickle cell disease by office‐based physicians in the United States, 1997‐2017. Pharmacoepidemiol Drug Saf 2019;28:1246-1250. [DOI: 10.1002/pds.4860] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Revised: 06/10/2019] [Accepted: 06/26/2019] [Indexed: 01/07/2023]